4-aminoantipirina, mínimo 98 %, pa, ACS, 10 g, envase de vidrio

3,4-Dihydro-2h-1,4-benzothiazine-1,1-dione, 97%, 100mg

Pyrrolidin-2-yl-acetic acid hydrochloride, 97.0%, 1g

(3-((2-Methoxyethyl)carbamoyl)phenyl)boronic acid, 97%, 1g

6-Methoxy-2-azaspiro[3.3]heptane hydrochloride, 97%, 10g

3-(PHENYLMETHOXY)-1,1-CYCLOBUTANEDICARBOXYLIC ACID DIISOPROPYL DIESTER, 95.0%, 10g

Ethyl 1H-pyrrolo[3,2-c]pyridine-2-carboxylate, 95.0%, 25g

5-Bromo-2-ethoxy-1,3-dimethylbenzene, 98%, 1g

METHYL 4-BROMO-2-(DIBROMOMETHYL)-6-FLUOROBENZOATE, 95%, 100mg

(4-((2-Acrylamidoethyl)carbamoyl)-3-fluorophenyl)boronic acid, 97.0%, 1g

(2r,3r,5r,6r,7r,8r)-cuban-1-amine hydrochloride, 95.0%, 1g

n-Butyl trifluoroacetate, 97.0%, 5g

Tacalcitol, 98.96%, 5mg